Eggert Stockfleth , MD, PhD 1 , Ketty Peris , MD 2 , Carlos Guillen , MD 3 , Rino Cerio , FRCP, FRCPPath 4 , Nicole Basset-Seguin , MD 5 , Peter Foley , MBBS, BMEDSC, MD 6 , José Sanches , MD 7 , Alex Culshaw , BSc 8 , Sandra Erntoft , PhD 9 , Mark Lebwohl , MD 10
10 April 2015
Topical therapy is important in the treatment of actinic keratosis, but guidance for improving adherence/persistence during topical therapy is still lacking.
To utilize expert consensus to generate a list of recommendations to improve real-world efficacy when prescribing topical therapy for actinic keratosis.
An expert panel of eight dermatologists was convened to generate recommendations based on facilitated discussion and consensus generation using a modified Delphi session. The recommendations were ratified with the expert panel.
Facilitated discussion generated 31 issues within five themes, which were prioritized using expert voting. Consensus was achieved on the importance of short and simple treatment regimens for maximizing patient compliance, physician awareness of the progression of actinic keratosis to squamous cell carcinoma, provision of appropriate patient information, and the use of effective communication strategies to educate physicians about actinic keratosis. Based on these key findings, eight recommendations were generated.